Effect Of Social Media On Body Weight And Eating Behaviour In Housewife Versus Worker Postmenopausal Women
Launched by CAIRO UNIVERSITY · Sep 23, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how social media affects body weight and eating habits in postmenopausal women, comparing those who work outside the home with those who are housewives. The goal is to understand whether heavy use of social media platforms like Facebook, YouTube, WhatsApp, Google Chrome, and Internet Explorer influences how these women manage their weight and eating behaviors.
To participate in this study, women must be between 50 and 60 years old and have not had a menstrual period for at least a year. They should also be regular users of social media. However, women with certain health conditions, such as uncontrolled high blood pressure, diabetes, or those taking specific medications, will not be eligible. If chosen to participate, women can expect to share information about their social media use and how it relates to their eating and weight. The study is not yet recruiting participants, but it aims to provide valuable insights into the impact of social media in this group of women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postmenopausal women (housewifes/workers) at least 12 months of menstrual cessation will be included in this study.
- • Their ages will range from 50 to 60 years old.
- • They will be categorized as average to heavy users of social media according to (social networking usage questionnaire (SONTUS).
- • The selected social media websites in this study will be Facebook, YouTube, what's app, Google chrome and Internet explorer.
- Exclusion Criteria:
- • Systematic disease (uncontrolled hypertension, diabetes mellitus).
- • Thyroid, liver and kidney dysfunctions.
- • Psycatric disorders
- • Women received any hormonal therapy or received corticosteroids in the last six months prior the study
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Trial Officials
Hala Mohamed Hanfy, PhD
Study Chair
Professor, Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported